77% of retail investor accounts lose money when trading CFDs with this provider.
77% of retail investor accounts lose money when trading CFDs with this provider.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
77% of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
77% of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
PFIZER is an American healthcare corporation based in New York that is focused on pharmaceuticals and consumer products. The company produces medicines for a number of medical fields, such as cardiology, immunology and neurology. The corporation is one of the world’s largest in the pharmaceutical industry.
The company currently has around 96,000 employees.
The company was expected to merge with Allergan plc in a deal valued at $160 billion, but was called off in April 2016 after the US Treasury due to inversions, a way of avoiding taxes through merging with a foreign company.
In 2018 PFIZER’s consumer health business found itself at the centre of a bidding war between GlaxoSmithKline Plc and Reckitt Benckiser Group Plc who are expected to table bids of up to $20 billion for the company.